Partnership with University of Strathclyde’s CMAC

AI SummaryClose X

N4 Pharma PLC has announced a collaboration with the University of Strathclyde's CMAC National Facility to advance its Nuvec® gene delivery platform. The partnership aims to accelerate the platform's development towards clinical readiness and explore broader therapeutic applications. The collaboration will involve characterizing additional dual-loaded Nuvec® preclinical candidates both in vitro and in vivo. Professor Yvonne Perrie, awarded an MBE in 2024 for services to pharmaceutical innovation and regulation, will contribute her expertise in drug delivery, RNA vaccines, and nanomedicine manufacturing to the project. This collaboration seeks to strengthen the commercial data package for Nuvec® and position it as a leading gene delivery platform.

Disclaimer*

UK 100

Latest directors dealings